Home › Borstkanker › Californië › Santa Monica
Borstkanker klinische studies in Santa Monica, CA
28 studies voor Borstkanker zoeken deelnemers op locaties in en rond Santa Monica (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RekruterenFase 3
- Beverly Hills Cancer Center, Beverly Hills · 6 mijl verwijderd
A Study of PHST001 in Advanced Solid Tumors
RekruterenFase 1
- Precision NextGen Oncology & Research Center, Beverly Hills · 6 mijl verwijderd
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
RekruterenFase 2
- Beverly Hills Cancer Center, Beverly Hills · 6 mijl verwijderd
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RekruterenFase 1
- Research Site, Santa Monica
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
RekruterenFase 1
- Kivu Trial Site, Santa Monica
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Rekruteren
- UCLA David Geffen School of Medicine, Santa Monica
A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
RekruterenFase 1
- Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills · 6 mijl verwijderd
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RekruterenFase 3
- Clinical Trial Site, Beverly Hills · 6 mijl verwijderd
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekruterenFase 1
- University of California, Los Angeles (UCLA), Santa Monica
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruterenFase 3
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
RekruterenFase 2
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
RekruterenFase 1/2
- Beverly Hills Cancer Center, Beverly Hills · 6 mijl verwijderd
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekruterenFase 3
- Saint John's Health Center - John Wayne Cancer Institute (JWCI), Santa Monica
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruterenFase 3
- Cedars-Sinai Cancer Beverly Hills, Beverly Hills · 6 mijl verwijderd
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RekruterenFase 1/2
- Research Site, Santa Monica
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
RekruterenFase 2
- UCLA Hematology/Oncology - Parkside ( Site 0021), Santa Monica
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekruterenFase 3
- St. John's Cancer Center, Santa Monica
- UCLA-Department of Medicine Hematology/Oncology-Parkside, Santa Monica
- UCLA-Hetamtology/Oncology_S Monica, Santa Monica
- en nog 1
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruterenFase 3
- Tower Cancer Research Foundation, Beverly Hills · 6 mijl verwijderd
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11 mijl verwijderd
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 mijl verwijderd
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
RekruterenFase 1
- Precision Next Gen Oncology & Research Center, Beverly Hills · 6 mijl verwijderd
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
RekruterenFase 2
- CS Cancer at Valley Oncology Medical Group, Tarzana · 11 mijl verwijderd
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekruterenFase 3
- University of California Los Angeles - Hematology / Oncology Parkside, Santa Monica
E-Mindfulness Approaches for Living After Breast Cancer
RekruterenFase 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 mijl verwijderd
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekruterenFase 2
- University of California Los Angeles Rheumatology, Westwood, Los Angeles · 4 mijl verwijderd
- Precision NextGen Oncology & Research Center, Beverly Hills · 6 mijl verwijderd
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RekruterenFase 1/2
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
RekruterenFase 1
- University of California, Los Angeles, Santa Monica
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruterenFase 3
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11 mijl verwijderd
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
RekruterenFase 1/2
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
RekruterenObservatieonderzoek
- John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica
Borstkanker studies in andere steden
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Durham, NC64 studies
- Chicago, IL59 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Andere studies in Santa Monica
- Niet-kleincellige longkanker45 studies
- Colorectale kanker23 studies
- Kanker (alle vormen)22 studies
- Metastatische kanker19 studies
- Longkanker15 studies
- Eierstokkanker15 studies
- Prostaatkanker15 studies
- Plaveiselcelcarcinoom van hoofd en hals13 studies
- Hartfalen11 studies
- Endometriumkanker10 studies
- Maagkanker9 studies
- Aldermeesklierkanker9 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.